Barclays Reiterates Equal Weight Rating for Blue Owl Capital (NYSE:OWL)

Blue Owl Capital (NYSE:OWL)‘s stock had its “equal weight” rating restated by equities research analysts at Barclays in a research note issued to investors on Monday, MarketBeat.com reports. They currently have a $11.00 target price on the stock, down from their previous target price of $15.00. Barclays‘s price target would indicate a potential upside of 6.80% from the stock’s current price.

OWL has been the subject of several other reports. Raymond James Financial restated a “strong-buy” rating on shares of Blue Owl Capital in a report on Thursday, February 19th. UBS Group decreased their target price on shares of Blue Owl Capital from $16.50 to $12.00 and set a “neutral” rating for the company in a research note on Friday, February 20th. The Goldman Sachs Group lowered their price target on shares of Blue Owl Capital from $16.25 to $14.00 and set a “neutral” rating on the stock in a report on Friday, February 6th. Citigroup reiterated an “outperform” rating on shares of Blue Owl Capital in a report on Tuesday, January 27th. Finally, Evercore set a $14.00 target price on Blue Owl Capital in a research note on Friday, February 6th. Two analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Blue Owl Capital currently has an average rating of “Moderate Buy” and an average price target of $18.44.

Blue Owl Capital Stock Down 3.6%

Shares of Blue Owl Capital stock opened at $10.30 on Monday. Blue Owl Capital has a 12 month low of $9.73 and a 12 month high of $21.88. The stock has a market cap of $16.01 billion, a PE ratio of 103.01, a price-to-earnings-growth ratio of 0.89 and a beta of 1.15. The business has a fifty day simple moving average of $13.74 and a 200-day simple moving average of $15.59.

Blue Owl Capital (NYSE:OWL) last announced its quarterly earnings data on Thursday, February 5th. The company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.22 by $0.05. Blue Owl Capital had a return on equity of 20.93% and a net margin of 2.75%.The firm had revenue of $701.47 million during the quarter, compared to the consensus estimate of $712.75 million. Analysts expect that Blue Owl Capital will post 0.92 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the stock. Royal Bank of Canada boosted its position in Blue Owl Capital by 50.0% during the first quarter. Royal Bank of Canada now owns 397,990 shares of the company’s stock worth $7,976,000 after purchasing an additional 132,637 shares during the period. Nisa Investment Advisors LLC lifted its stake in shares of Blue Owl Capital by 63.6% in the second quarter. Nisa Investment Advisors LLC now owns 9,326 shares of the company’s stock worth $179,000 after buying an additional 3,626 shares during the last quarter. Envestnet Asset Management Inc. lifted its stake in shares of Blue Owl Capital by 4.0% in the second quarter. Envestnet Asset Management Inc. now owns 954,764 shares of the company’s stock worth $18,341,000 after buying an additional 36,784 shares during the last quarter. Teacher Retirement System of Texas boosted its holdings in shares of Blue Owl Capital by 14.4% during the 2nd quarter. Teacher Retirement System of Texas now owns 90,259 shares of the company’s stock worth $1,734,000 after buying an additional 11,378 shares during the period. Finally, Keybank National Association OH grew its stake in Blue Owl Capital by 5.2% in the 2nd quarter. Keybank National Association OH now owns 18,326 shares of the company’s stock valued at $352,000 after buying an additional 906 shares during the last quarter. 35.85% of the stock is owned by institutional investors.

Blue Owl Capital Company Profile

Blue Owl Capital is a global alternative asset manager that focuses on private credit, direct lending and equity-related strategies for institutional investors. Headquartered in New York, the firm develops and manages a range of private markets products designed to provide capital solutions to middle-market and larger corporate borrowers, as well as liquidity and partnership arrangements with private equity firms and other alternative managers.

Its core activities include direct lending and credit strategies that provide senior, unitranche and other structured loan products to companies across industries.